The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

Josep Comín‐Colet; Mitja Lainščak; Kenneth Dickstein; Gerasimos Filippatos; P. Connor Johnson

doi:10.1093/eurheartj/ehr504

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

Josep Comín‐Colet, Mitja Lainščak, Kenneth Dickstein, Gerasimos Filippatos, P. Connor Johnson, Thomas F. Lüscher, Claudio Mori, Ronnie Willenheimer, Piotr Ponikowski, Stefan D. Anker

Oxford University Press (2012) • Volume 34, Issue 1, Pages 30-38

PDF Available

Abstract

HRQoL is impaired in iron-deficient patients with CHF. Intravenous FCM significantly improved HRQoL after 4 weeks, and throughout the remaining study period. The positive effects of FCM were independent of anaemia status.

Quick Actions

Read Full Paper

Publication Info

DOI

10.1093/eurheartj/ehr504

Language

English

Topic

Erythropoietin and Anemia Treatment

Keywords

Medicine, Placebo, Quality of life (healthcare), Internal medicine, Heart failure, Iron deficiency, Ejection fraction, Randomized controlled trial, Visual analogue scale, Physical therapy, Anemia

Published

January 31, 2012

Citations

157 citations

FWCI

9.00

External Resources

DOI Link OpenAlex

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Primary Health Care: a strategic framework for the prevention and control of chronic non-communicable disease

Suggested Papers

Suggested Papers

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Primary Health Care: a strategic framework for the prevention and control of chronic non-communicable disease